RS57075B1 - Kombinacija leka - Google Patents
Kombinacija lekaInfo
- Publication number
- RS57075B1 RS57075B1 RS20180229A RSP20180229A RS57075B1 RS 57075 B1 RS57075 B1 RS 57075B1 RS 20180229 A RS20180229 A RS 20180229A RS P20180229 A RSP20180229 A RS P20180229A RS 57075 B1 RS57075 B1 RS 57075B1
- Authority
- RS
- Serbia
- Prior art keywords
- drug combination
- drug
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361799177P | 2013-03-15 | 2013-03-15 | |
PCT/GB2014/050834 WO2014140648A1 (en) | 2013-03-15 | 2014-03-17 | Drug combination |
EP14712717.9A EP2968313B1 (en) | 2013-03-15 | 2014-03-17 | Drug combination |
Publications (1)
Publication Number | Publication Date |
---|---|
RS57075B1 true RS57075B1 (sr) | 2018-06-29 |
Family
ID=50382477
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20180229A RS57075B1 (sr) | 2013-03-15 | 2014-03-17 | Kombinacija leka |
Country Status (23)
Country | Link |
---|---|
US (3) | US9717732B2 (sr) |
EP (2) | EP2968312B1 (sr) |
JP (1) | JP6560986B2 (sr) |
KR (1) | KR102177982B1 (sr) |
CN (1) | CN105142638B (sr) |
AU (1) | AU2014229739B2 (sr) |
CA (2) | CA2902403C (sr) |
CY (2) | CY1120020T1 (sr) |
DK (2) | DK2968313T3 (sr) |
ES (2) | ES2660317T3 (sr) |
HR (1) | HRP20180684T1 (sr) |
HU (2) | HUE038899T2 (sr) |
IL (1) | IL240846A0 (sr) |
LT (1) | LT2968313T (sr) |
MX (1) | MX2015011778A (sr) |
NO (2) | NO2997033T3 (sr) |
PL (2) | PL2968312T3 (sr) |
PT (2) | PT2968313T (sr) |
RS (1) | RS57075B1 (sr) |
RU (1) | RU2666624C2 (sr) |
SI (2) | SI2968312T1 (sr) |
TR (1) | TR201802725T4 (sr) |
WO (2) | WO2014140648A1 (sr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2902403C (en) | 2013-03-15 | 2021-06-01 | Verona Pharma Plc | Pde3/pde4 inhibitor/muscarinic receptor antagonist combination |
PT3231444T (pt) | 2014-05-12 | 2020-03-05 | Verona Pharma Plc | Novo tratamento |
US20170119744A1 (en) * | 2014-06-18 | 2017-05-04 | Cipla Limited | Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent |
SI3193835T1 (en) | 2014-09-15 | 2018-06-29 | Verona Pharma PLC Bradley Court | Liquid inhalation preparation containing rpl554 |
GB201502260D0 (en) * | 2015-02-11 | 2015-04-01 | Verona Pharma Plc | Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound |
US9827288B2 (en) * | 2015-09-21 | 2017-11-28 | Mycomagic Biotechnology Co., Ltd. | Method for treating a refractory or relapsed lung cancer |
GB201613054D0 (en) | 2016-07-28 | 2016-09-14 | Verona Pharma Plc | New compound and process |
GB2578093B (en) * | 2018-10-09 | 2020-11-18 | Verona Pharma Plc | Liquid pharmaceutical composition comprising RPL554 and HFA-134A |
WO2020150460A1 (en) * | 2019-01-18 | 2020-07-23 | Milne Iii Donald A | Micronized aspirin formulation |
GB201911517D0 (en) | 2019-08-12 | 2019-09-25 | Verona Pharma Plc | Pharmaceutical composition |
GB202002786D0 (en) | 2020-02-27 | 2020-04-15 | Verona Pharma Plc | Liquid pharmaceutical composition |
WO2022228544A1 (zh) | 2021-04-29 | 2022-11-03 | 苏州盛迪亚生物医药有限公司 | 异喹啉酮类化合物及其用途 |
CN117457114B (zh) * | 2023-12-25 | 2024-03-12 | 大连锦辉盛世科技有限公司 | 一种西药药学成分数据智能存储管理方法 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
US5874063A (en) | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
WO1992022286A1 (en) | 1991-06-12 | 1992-12-23 | Minnesota Mining And Manufacturing Company | Albuterol sulfate suspension aerosol formulations |
ES2159678T3 (es) | 1991-12-18 | 2001-10-16 | Minnesota Mining & Mfg | Formulaciones de aerosol en suspension. |
US5983956A (en) | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
SE9501384D0 (sv) | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
DE19626373A1 (de) * | 1996-07-02 | 1998-01-08 | Boehringer Ingelheim Kg | Neuartige Verwendung von Wirkstoffen, welche die Funktion von nichtneuronalem Acetylcholin beeinflussen |
US6040344A (en) | 1996-11-11 | 2000-03-21 | Sepracor Inc. | Formoterol process |
EP1073417B1 (en) | 1998-04-18 | 2002-12-04 | Glaxo Group Limited | Pharmaceutical aerosol formulation |
GB9808802D0 (en) | 1998-04-24 | 1998-06-24 | Glaxo Group Ltd | Pharmaceutical formulations |
SE9804000D0 (sv) | 1998-11-23 | 1998-11-23 | Astra Ab | New composition of matter |
JP4685243B2 (ja) | 1999-03-31 | 2011-05-18 | ベローナ・ファーマ・ピーエルシー | ピリミド[6,1−a]イソキノリン−4−オン誘導体 |
JP2002541183A (ja) | 1999-04-14 | 2002-12-03 | グラクソ グループ リミテッド | 医薬用エアゾール製剤 |
UA73965C2 (en) | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
DE10110772A1 (de) | 2001-03-07 | 2002-09-12 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren |
GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
ATE365720T1 (de) | 2001-03-08 | 2007-07-15 | Glaxo Group Ltd | Agonisten von beta-adrenorezeptoren |
JP4143413B2 (ja) | 2001-03-22 | 2008-09-03 | グラクソ グループ リミテッド | β2−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体 |
EP1425001B1 (en) | 2001-09-14 | 2008-12-17 | Glaxo Group Limited | Phenethanolamine derivatives for treatment of respiratory diseases |
WO2003042160A1 (en) | 2001-11-13 | 2003-05-22 | Theravance, Inc. | Aryl aniline beta-2 adrenergic receptor agonists |
EP1452179A1 (en) * | 2003-02-27 | 2004-09-01 | CHIESI FARMACEUTICI S.p.A. | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
AU2005210084B2 (en) * | 2004-02-06 | 2010-06-24 | Meda Pharma Gmbh & Co. Kg | Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases |
US20060211752A1 (en) | 2004-03-16 | 2006-09-21 | Kohn Leonard D | Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
ES2257152B1 (es) | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
EP1761279A1 (en) * | 2004-05-31 | 2007-03-14 | Laboratorios Almirall, S.A. | Combinations comprising antimuscarinic agents and pde4 inhibitors |
CN1843453A (zh) * | 2005-04-06 | 2006-10-11 | 上海绿谷(集团)有限公司 | 一种治疗不孕症的中药组合物及其制备方法 |
RU2008119322A (ru) | 2005-10-19 | 2009-11-27 | Рэнбакси Лабораториз Лимитед (In) | Композиции ингибиторов фосфодиэстеразы iv типа |
EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
US20100009934A1 (en) * | 2008-06-09 | 2010-01-14 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
GB0919742D0 (en) | 2009-11-11 | 2009-12-30 | Millipore Corp | Optical sensor |
SI2603509T1 (sl) * | 2010-08-09 | 2014-10-30 | Verona Pharma Plc | Kristalinična oblika spojine PIRIMIDIO(6,1-A) IZOKINOLIN-4-ENA |
CA2902403C (en) | 2013-03-15 | 2021-06-01 | Verona Pharma Plc | Pde3/pde4 inhibitor/muscarinic receptor antagonist combination |
-
2014
- 2014-03-17 CA CA2902403A patent/CA2902403C/en active Active
- 2014-03-17 RU RU2015144083A patent/RU2666624C2/ru active
- 2014-03-17 JP JP2015562338A patent/JP6560986B2/ja active Active
- 2014-03-17 EP EP14712716.1A patent/EP2968312B1/en active Active
- 2014-03-17 MX MX2015011778A patent/MX2015011778A/es active IP Right Grant
- 2014-03-17 EP EP14712717.9A patent/EP2968313B1/en active Active
- 2014-03-17 SI SI201430689T patent/SI2968312T1/en unknown
- 2014-03-17 ES ES14712717.9T patent/ES2660317T3/es active Active
- 2014-03-17 LT LTEP14712717.9T patent/LT2968313T/lt unknown
- 2014-03-17 US US14/771,097 patent/US9717732B2/en active Active
- 2014-03-17 HU HUE14712716A patent/HUE038899T2/hu unknown
- 2014-03-17 DK DK14712717.9T patent/DK2968313T3/en active
- 2014-03-17 PL PL14712716T patent/PL2968312T3/pl unknown
- 2014-03-17 SI SI201430643T patent/SI2968313T1/en unknown
- 2014-03-17 ES ES14712716.1T patent/ES2666098T3/es active Active
- 2014-03-17 TR TR2018/02725T patent/TR201802725T4/tr unknown
- 2014-03-17 DK DK14712716.1T patent/DK2968312T3/en active
- 2014-03-17 WO PCT/GB2014/050834 patent/WO2014140648A1/en active Application Filing
- 2014-03-17 PT PT147127179T patent/PT2968313T/pt unknown
- 2014-03-17 RS RS20180229A patent/RS57075B1/sr unknown
- 2014-03-17 KR KR1020157028970A patent/KR102177982B1/ko active IP Right Grant
- 2014-03-17 PT PT147127161T patent/PT2968312T/pt unknown
- 2014-03-17 PL PL14712717T patent/PL2968313T3/pl unknown
- 2014-03-17 HU HUE14712717A patent/HUE037275T2/hu unknown
- 2014-03-17 WO PCT/GB2014/050833 patent/WO2014140647A1/en active Application Filing
- 2014-03-17 CN CN201480015150.8A patent/CN105142638B/zh active Active
- 2014-03-17 AU AU2014229739A patent/AU2014229739B2/en active Active
- 2014-03-17 US US14/771,109 patent/US9700558B2/en active Active
- 2014-03-17 CA CA2902400A patent/CA2902400C/en active Active
- 2014-04-18 NO NO14798188A patent/NO2997033T3/no unknown
- 2014-11-12 NO NO14798816A patent/NO3068699T3/no unknown
-
2015
- 2015-08-26 IL IL240846A patent/IL240846A0/en unknown
-
2017
- 2017-06-05 US US15/614,440 patent/US10471063B2/en active Active
-
2018
- 2018-03-12 CY CY20181100299T patent/CY1120020T1/el unknown
- 2018-04-26 CY CY20181100438T patent/CY1120346T1/el unknown
- 2018-04-30 HR HRP20180684TT patent/HRP20180684T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201905426B (en) | Drug combinations | |
HRP20180684T1 (hr) | Kombinacija lijekova | |
GB201307385D0 (en) | Syringes | |
GB201322602D0 (en) | Pharmaceutical compounds | |
ZA201506252B (en) | Syringe | |
GB201306610D0 (en) | Pharmaceutical compounds | |
ZA201602047B (en) | Pharmaceutical compounds | |
ZA201507576B (en) | Pharmaceutical combination drug | |
GB201308440D0 (en) | Therapeutic | |
GB201408677D0 (en) | Syringes | |
EP2978473A4 (en) | AUTOMATIC RETRACTABLE SYRINGE | |
GB201318668D0 (en) | Sonosensitive therapeutic | |
GB201312386D0 (en) | Pharmaceutical compounds | |
GB201306901D0 (en) | Combination | |
GB201316662D0 (en) | Pharmaceutical Combination | |
GB201320786D0 (en) | Medicament | |
ZA201501382B (en) | Medical claims | |
GB201310496D0 (en) | Pharmaceutical combinations | |
GB201301723D0 (en) | Pharmaceutical combinations | |
GB201317166D0 (en) | Pharmaceutical compounds | |
GB201316791D0 (en) | Pharmaceutical Compounds | |
GB201316780D0 (en) | Pharmaceutical compounds | |
GB201315733D0 (en) | Pharmaceutical compounds | |
GB201315734D0 (en) | Pharmaceutical compounds | |
GB201312464D0 (en) | Pharmaceutical compounds |